BackBioAffinity Technologies Overview

BioAffinity Technologies Other Current Liabilities

Latest other current liabilities for BIAF: $1.4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$1.41M
↑ 34.97% YoYΔ $366458.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioAffinity Technologies Other Current Liabilities History

Loading

BioAffinity Technologies vs. peers: Other Current Liabilities Comparison

Loading

BioAffinity Technologies Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioAffinity Technologies (BIAF) FAQ

As of the most recent data (June 2026), BIAF shows a other current liabilities of $1.4M. That compares with $1M in the prior-year period — up 35.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIAF's other current liabilities is now $1.4M (was $1M) — a 35.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioAffinity Technologies is outperforming or lagging.

Tracking BIAF's other current liabilities over time shows whether BioAffinity Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M That compares with $1M in the prior-year period — up 35.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has BioAffinity Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1.4M) with ownership activity and broader fundamentals.